CNSX:TRULPharmaceuticals
Why Trulieve Cannabis (CNSX:TRUL) Is Up 25.7% After Breakthrough NYSE Listing Approval And What's Next
Trulieve Cannabis recently secured approval to list its subordinate voting shares on the New York Stock Exchange, becoming the first U.S. cannabis company on a senior U.S. exchange following federal reclassification of medical marijuana to Schedule III.
This uplift, supported by a restructuring to focus on state-licensed medical marijuana operations, positions Trulieve to pursue expansion in emerging medical markets such as Georgia and Texas under a clearer regulatory framework.
We’ll now...